{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:51:32Z","timestamp":1770738692306,"version":"3.49.0"},"reference-count":31,"publisher":"CSIRO Publishing","issue":"2","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1071\/journalslicense"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Genital Mycoplasmas and Ureaplasmas pose diagnostic and therapeutic challenges due to their varying pathogenicity and increasing antimicrobial resistance. This study aimed to characterise the positivity, clinical associations, and treatment outcomes of Mycoplasmoides genitalium, Metamycoplasma hominis, Ureaplasma urealyticum and Ureaplasma parvum in an urban clinic in Tokyo, Japan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study was conducted at a single clinic in Tokyo, Japan. Electronic medical records of patients who underwent polymerase chain reaction testing for the four target pathogens between January 2023 and April 2024 were included in the study. To minimise confounding, a sub-analysis was performed on a chlamydia\/gonorrhoea-negative subset. The statistical association between specific organisms and symptoms was assessed, and the treatment success rate (negative test-of-cure after \u22653\u00a0weeks) was evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 524 patients tested, 213 (40.7%) tested positive for at least one pathogen. M. genitalium was the most prevalent (81\/213, 38.0%), and showed a robust association with dysuria (P\u00a0&amp;lt;\u00a00.01) and purulent genital discharge (P\u00a0=\u00a00.03) in the chlamydia\/gonorrhoea-negative subset. In contrast, M. hominis and Ureaplasma spp. were predominantly associated with colonisation or non-specific symptoms. The clinical success rate for M. genitalium (minocycline followed by sitafloxacin) was suboptimal at 68.8%. Notably, U. parvum showed an alarmingly low success rate against moxifloxacin (28.6% in the subset). The overall test-of-cure completion rate was low (60.1%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a Tokyo clinical setting, M. genitalium was the most prevalent species and the primary driver of symptoms, whereas M. hominis and Ureaplasma spp. frequently suggest colonisation. Management remains challenging due to suboptimal cure rates and poor follow-up adherence. These findings support a tiered diagnostic strategy that prioritises exclusion of major sexually transmitted infections and emphasises species-specific management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1071\/sh25204","type":"journal-article","created":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T19:27:00Z","timestamp":1768850820000},"source":"Crossref","is-referenced-by-count":0,"title":["Clinical epidemiology and management challenges of genital Mycoplasma and Ureaplasma infections: a retrospective observational study at a Japanese urban clinic"],"prefix":"10.1071","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-0276","authenticated-orcid":true,"given":"Nobuaki","family":"Mori","sequence":"first","affiliation":[{"name":"ADepartment of Medicine, Division of Clinical Infectious Diseases, Showa Medical University School of Medicine, Tokyo, Japan."},{"name":"BKARADA Internal Medicine Clinic, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenya","family":"Yukawa","sequence":"additional","affiliation":[{"name":"BKARADA Internal Medicine Clinic, Tokyo, Japan."},{"name":"CDepartment of Infectious Diseases, Cancer Institute Hospital of JFCR, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Oda","sequence":"additional","affiliation":[{"name":"ADepartment of Medicine, Division of Clinical Infectious Diseases, Showa Medical University School of Medicine, Tokyo, Japan."},{"name":"BKARADA Internal Medicine Clinic, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Tanaka","sequence":"additional","affiliation":[{"name":"BKARADA Internal Medicine Clinic, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Tokimatsu","sequence":"additional","affiliation":[{"name":"ADepartment of Medicine, Division of Clinical Infectious Diseases, Showa Medical University School of Medicine, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Sato","sequence":"additional","affiliation":[{"name":"BKARADA Internal Medicine Clinic, Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"67","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"10","key":"2026020917313852700_R1","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1086\/656739","article-title":"Is Mycoplasma genitalium in women the \u201cNew Chlamydia?\u201d A community-based prospective cohort study.","volume":"51","author":"Oakeshott","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"6","key":"2026020917313852700_R2","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.2105\/AJPH.2005.074062","article-title":"Mycoplasma genitalium among young adults in the United States: an emerging sexually transmitted infection.","volume":"97","author":"Manhart","year":"2007","journal-title":"Am J Public Health"},{"issue":"9","key":"2026020917313852700_R3","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s10482-018-1047-3","article-title":"Phylogenetic framework for the phylum Tenericutes based on genome sequence data: proposal for the creation of a new order Mycoplasmoidales ord. nov., containing two new families Mycoplasmoidaceae fam. nov. and Metamycoplasmataceae fam. nov. harbouring Eperythrozoon, Ureaplasma and five novel genera.","volume":"111","author":"Gupta","year":"2018","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"4","key":"2026020917313852700_R4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021.","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"issue":"7","key":"2026020917313852700_R5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanmic.2024.101047","article-title":"Evolving patterns of macrolide and fluoroquinolone resistance in Mycoplasma genitalium: an updated systematic review and meta-analysis.","volume":"6","author":"Chua","year":"2025","journal-title":"Lancet Microbe"},{"issue":"7","key":"2026020917313852700_R6","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1093\/jac\/dkaf142","article-title":"Efficacy and tolerability of the combination of minocycline and metronidazole for macrolide-resistant Mycoplasma genitalium.","volume":"80","author":"Htaik","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2026020917313852700_R7","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-025-00722-7","article-title":"Antimicrobial resistance in curable sexually transmitted infections.","volume":"22","author":"Giacani","year":"2025","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"1","key":"2026020917313852700_R8","doi-asserted-by":"publisher","DOI":"10.1093\/jambio\/lxae308","article-title":"Global prevalence, resistance rates, and underlying resistance mechanisms of clinical Mycoplasma and Ureaplasma species.","volume":"136","author":"Ramaloko","year":"2025","journal-title":"J Appl Microbiol"},{"issue":"4","key":"2026020917313852700_R9","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.siny.2008.11.009","article-title":"Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis.","volume":"14","author":"Waites","year":"2009","journal-title":"Semin Fetal Neonatal Med"},{"issue":"5","key":"2026020917313852700_R10","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1080\/14767058.2020.1733517","article-title":"Vaginal Ureaplasma urealyticum or Mycoplasma hominis and preterm delivery in women with threatened preterm labor.","volume":"35","author":"Miyoshi","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"3","key":"2026020917313852700_R11","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e14543","article-title":"Prevalence of Mycoplasma hominis, Ureaplasma urealyticum, and Ureaplasma parvum detection in urine and respiratory tract samples in Hiroshima, Japan.","volume":"9","author":"Tadera","year":"2023","journal-title":"Heliyon"},{"issue":"10","key":"2026020917313852700_R12","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1177\/0956462415597620","article-title":"Ureaplasma parvum and Mycoplasma genitalium are found to be significantly associated with microscopy-confirmed urethritis in a routine genitourinary medicine setting.","volume":"27","author":"Cox","year":"2016","journal-title":"Int J STD AIDS"},{"issue":"12","key":"2026020917313852700_R13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113771","article-title":"Are Ureaplasma spp. a cause of nongonococcal urethritis? A systematic review and meta-analysis.","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"2026020917313852700_R14","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1111\/jdv.15146","article-title":"Should we be testing for urogenital Mycoplasma hominis, Ureaplasma parvum and Ureaplasma urealyticum in men and women? - a position statement from the European STI Guidelines Editorial Board.","volume":"32","author":"Horner","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2026020917313852700_R15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jiac.2015.03.010","article-title":"Development and clinical application of an InvaderPlus\u00ae assay for the detection of genital mycoplasmas.","volume":"21","author":"Takanashi","year":"2015","journal-title":"J Infect Chemother"},{"issue":"5","key":"2026020917313852700_R16","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/jdv.17972","article-title":"2021 European guideline on the management of Mycoplasma genitalium infections.","volume":"36","author":"Jensen","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2026020917313852700_R17","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jiac.2019.12.007","article-title":"Prevalence of N. gonorrhoeae, C. trachomatis, M. genitalium, M. hominis and Ureaplasma spp. in the anus and urine among Japanese HIV-infected men who have sex with men.","volume":"26","author":"Kato","year":"2020","journal-title":"J Infect Chemother"},{"issue":"6","key":"2026020917313852700_R18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3201\/eid2106.142013","article-title":"Drug resistance-associated mutations in Mycoplasma genitalium in female sex workers, Japan.","volume":"21","author":"Deguchi","year":"2015","journal-title":"Emerg Infect Dis"},{"key":"2026020917313852700_R19","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7537318","article-title":"Mycoplasma genitalium: an emerging sexually transmitted infection.","volume":"2016","author":"Munoz","year":"2016","journal-title":"Scientifica"},{"issue":"10","key":"2026020917313852700_R20","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1128\/JCM.00818-17","article-title":"Molecular diagnostics update for the emerging (if not already widespread) sexually transmitted infection agent Mycoplasma genitalium: Just about ready for prime time.","volume":"55","author":"Munson","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"1","key":"2026020917313852700_R21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/jac\/dkae403","article-title":"Prolonged sitafloxacin and doxycycline combination regimen for treating infections by highly resistant Mycoplasma genitalium.","volume":"80","author":"Ando","year":"2025","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"2026020917313852700_R22","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad590","article-title":"Efficacy of sitafloxacin for Mycoplasma genitalium in an era of increasing antimicrobial resistance.","volume":"10","author":"Samra","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"2026020917313852700_R23","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05659-3","article-title":"Macrolide and fluoroquinolone associated mutations in Mycoplasma genitalium in a retrospective study of male and female patients seeking care at a STI Clinic in Guangzhou, China, 2016-2018.","volume":"20","author":"Ke","year":"2020","journal-title":"BMC Infect Dis"},{"issue":"6","key":"2026020917313852700_R24","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01868-24","article-title":"Antimicrobial susceptibility and genetic mechanisms of resistance of Ureaplasma isolates in North America between 2012 and 2023.","volume":"69","author":"Waites","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"2026020917313852700_R25","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00226-24","article-title":"Evaluation of commercial, customized microdilution plates for Ureaplasma parvum, Ureaplasma urealyticum, and Mycoplasma hominis antimicrobial susceptibility testing and determination of antimicrobial resistance prevalence in France.","volume":"62","author":"Pereyre","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"2","key":"2026020917313852700_R26","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001477","article-title":"Antibiotic resistance among clinical Ureaplasma isolates from Cuban individuals between 2013 and 2018.","volume":"71","author":"Preval","year":"2022","journal-title":"J Med Microbiol"},{"issue":"2","key":"2026020917313852700_R27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/jac\/dks417","article-title":"Analysis of the quinolone-resistance determining region of the gyrA gene and the analogous region of the parC gene in Ureaplasma parvum and Ureaplasma urealyticum detected in first-void urine of men with non-gonococcal urethritis.","volume":"68","author":"Kamiya","year":"2013","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2026020917313852700_R28","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1128\/AAC.04262-14","article-title":"In vitro activity of five quinolones and analysis of the quinolone resistance-determining regions of gyrA, gyrB, parC, and parE in Ureaplasma parvum and Ureaplasma urealyticum clinical isolates from perinatal patients in Japan.","volume":"59","author":"Kawai","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"2026020917313852700_R29","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02560-19","article-title":"Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying quinolone resistance.","volume":"64","author":"Yang","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"18","key":"2026020917313852700_R30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241813836","article-title":"Cervical and vaginal microbiomes in early miscarriages and ongoing pregnancy with and without dydrogesterone usage.","volume":"24","author":"Gryaznova","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2026020917313852700_R31","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13111004","article-title":"Molecular exploration of Mycoplasma fermentans and Mycoplasma genitalium in Mexican Women with Cervicitis.","volume":"13","author":"Bustos-L\u00f3pez","year":"2024","journal-title":"Pathogens"}],"container-title":["Sexual Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25204\/1856068\/sh25204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/connectsci.au\/sh\/article-pdf\/doi\/10.1071\/SH25204\/1856068\/sh25204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T22:31:45Z","timestamp":1770676305000},"score":1,"resource":{"primary":{"URL":"https:\/\/connectsci.au\/sh\/article\/23\/2\/SH25204\/268477\/Clinical-epidemiology-and-management-challenges-of"}},"subtitle":[],"editor":[{"given":"Michael","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4,9]]}},"URL":"https:\/\/doi.org\/10.1071\/sh25204","relation":{},"ISSN":["1448-5028","1449-8987"],"issn-type":[{"value":"1448-5028","type":"print"},{"value":"1449-8987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"article-number":"SH25204"}}